Skip to Content Skip to Content

Neuroscience

How does opioid exposure affect brain development in young children?
Two people standing in a building entryway. Windows are on their left, a yellow wall with a portrait are on their right. They're both looking into the camera and smiling.

The new NIH-funded work from researchers Dylan Tisdall of Penn Medicine and Allyson Mackey of the School of Arts and Sciences will work to develop an MRI method geared specifically to three- to five-year-olds and calculate how exposure to opioids can impede neurocognitive development of children in that age range.

How does opioid exposure affect brain development in young children?

That’s the question Allyson Mackey and Dylan Tisdall hope to answer, through a new grant from an NIH initiative focused on addiction research.

Michele W. Berger

The science of sensations
Smiling scientist stands in a lab

Ishmail Abdus-Saboor has carved out a path studying the biology of touch, pain, and itch.

The science of sensations

To confront the ills of the opioid epidemic, scientists must develop a fundamental understanding of the biology of pain. Biologist Ishmail Abdus-Saboor’s work is setting the stage for screening alternative drugs and uncovering new pathways that an opioid-alternative could target.

Katherine Unger Baillie

Mounting brain organoid research reignites ethical debate
outline of human brain

Mounting brain organoid research reignites ethical debate

Penn neuroscientists call for an ethical framework grounded in scientific principles for transplanting human “mini-brains” into animals as the field evolves.

Penn Today Staff

How neuroscience could explain the rise of addictions, heart disease, and diabetes in 21st century America

How neuroscience could explain the rise of addictions, heart disease, and diabetes in 21st century America

Peter Sterling of the Perelman School of Medicine wrote about the neuroscience behind modern maladies like addiction: “Lacking small pulses of dopamine, we grow uncomfortable and seek relief with substances that act powerfully on the reward circuit to release dopamine in great surges.”

Penn, Drexel get $22 million to study Parkinson’s, Alzheimer’s, other dementias

Penn, Drexel get $22 million to study Parkinson’s, Alzheimer’s, other dementias

Penn’s Center for Neurodegenerative Disease Research has been awarded funding to explore a variety of dementias. The center is led by Virginia Man-Yee Lee and John Q. Trojanowski and the research will be conducted by Alice Chen-Plotkin and Murray Grossman, all of the Perelman School of Medicine.

A model for brain activity during brain stimulation therapy
an abstract depiction of a brain in multi-colors

A model for brain activity during brain stimulation therapy

Combined with data from other stimulation experiments , these models could help researchers determine the specific patterns of brain activity to target for improving memory.

Penn Today Staff